Tuesday, December 29, 2020

Zydus Cadila receives DCGI nod for NAFLD drug in India

Zydus Cadila receives DCGI nod for NAFLD drug in India The Drug Controller General of India (DCGI) has approved the new drug application (NDA) for Saroglitazar Mg for the treatment of non-alcoholic fatty liver disease (NAFLD) in India, Zydus Cadila said in a regulatory filing.

from Moneycontrol Business News https://ift.tt/2MjQTfu
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

IREDA shares rise 1.1% as board announces meeting date for fund raise via QIP

IREDA shares rose by 1.1% to Rs 209.50 on news of a board meeting set for January 23, 2025, to approve fund-raising via Qualified Institutio...